The biologics license application for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma was accepted by the FDA with priority review.

QIAstat-Dx uses real-time PCR technology to multiply genetic targets within the same reaction and deliver test results in around one hour.

Football legends Michael Vick and Michael Strahan are set to enter the College Football Hall of Fame.

Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins CNBC's 'Special Report' as President-elect Donald Trump is inaugurated as the 47th U.S. president, becoming the second to serve two non-consecutive terms.

Broadvoice, a leading global customer experience technology provider, announced today the launch of its 2025 CX World Tour, designed to introduce partners, distributors and end-users to its new Global Partner Program and award-winning

REVEAL GENOMICS, S.L., a Barcelona-based biotechnology start-up seeking to revolutionize ... at 18:00 MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function Transdermal GFR System (TGFR) is a first-in-kind product for point ...

The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.

Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA) Biotest's fibrinogen aims to fulfill a high unmet medical need for additional fibrinogen to treat acquired fibrinogen deficiency

Our Bureau, Bengaluru Monday, January 20, 2025, 14:30 Hrs [IST]

The global AI in oncology market, valued at US$1.92 billion in 2023, is forecasted to grow at a robust CAGR of 29.4%, reaching US$2.45 billion in 2024 and an impressive US$11.52 billion by 2030. The growth is attributed to the increasing healthcare expenditures,

Artificial intelligence has the capacity to transform the sport, whether that is scouting, coaching, injury prevention or extending careers

Bengaluru-based cell and gene therapy start-up Immuneel Therapeutics on Monday announced the launch of Qartemi -- the countr